Agenda Provectus Biopharmaceuticals, Inc.

Acciones

PVCT

US74373P1084

Diferido OTC Markets 20:55:02 13/05/2024 Varia. Cinco días. Varia. 1 de enero.
0,188 USD -3,24 % Gráfico intradía de Provectus Biopharmaceuticals, Inc. +6,46 % +95,83 %

Calendario de gráficos Provectus Biopharmaceuticals, Inc.

6e4d6904246163a.bsZ-nRMhWi2uLexlkfRYnjZs5mc4490XytvvZc-hjUY.HYUw1iBlPVv7FYst_LEz9FA6rCpzlr9Snp6bIYrz0iwAhwveIlNrY8Fngw~6b144f972ed94eda5d846a1472a4c151

Próximos eventos en Provectus Biopharmaceuticals, Inc.

15/05/2024 Society for Investigative Dermatology Meeting

Eventos pasados en Provectus Biopharmaceuticals, Inc.

05/04/2024 American Association for Cancer Research Meeting
22/02/2024 21:00 Business Update Call
06/11/2023 Society for Melanoma Research Congress - Combination PV-10 autolytic immunotherapy
06/11/2023 Society for Melanoma Research Congress - Percutaneous autolytic immunotherapy
01/11/2023 Society for Immunotherapy of Cancer Meeting
01/12/2022 Melanoma Bridge Conference
22/06/2022 22:00 Annual Genral Meeting
17/06/2022 International Society of Ocular Oncology Congress
06/06/2022 20:15 American Society of Clinical Oncology Meeting - Abstract No 9543
08/04/2022 American Association of Cancer Research Meeting - Abstract No 2720
10/03/2022 European Neuroendocrine Tumor Society Conference - Abstract No: 3455, I25
28/10/2021 Society for Melanoma Research Meeting - Cutaneous Melanoma
28/10/2021 Society for Melanoma Research Congress - Checkpoint Blockade
16/09/2021 ESMO Congress Conference - Abstract No - 4354
23/06/2021 22:00 Annual Genral Meeting
09/11/2020 Society of Immunotherapy of Cancer Meeting - Abstract Number : 585
19/09/2020 European Society for Medical Oncology Virtual Congress - Poster No -4397
19/09/2020 European Society for Medical Oncology Virtual Congress - Poster No -4281
22/06/2020 American Association for Cancer Research Virtual Meeting - Abstract number: 5393
29/05/2020 American Society of Clinical Oncology Virtual Asamblea General - Abstract No - 1
  1. Bolsa de valores
  2. Acciones
  3. Acción PVCT
  4. Agenda Provectus Biopharmaceuticals, Inc.